Monica Guffanti

2.1k total citations
28 papers, 349 citations indexed

About

Monica Guffanti is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Monica Guffanti has authored 28 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Monica Guffanti's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV-related health complications and treatments (5 papers). Monica Guffanti is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (9 papers) and HIV-related health complications and treatments (5 papers). Monica Guffanti collaborates with scholars based in Italy, United States and Switzerland. Monica Guffanti's co-authors include Adriano Lazzarin, Antonella Castagna, Nicola Gianotti, Laura Galli, Alba Bigoloni, Hamid Hasson, Stefania Salpietro, Elena Seminari, Anna Danise and G. Pellicciotta and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.

In The Last Decade

Monica Guffanti

25 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Guffanti Italy 11 206 158 143 82 39 28 349
Tanakorn Apornpong Thailand 10 134 0.7× 129 0.8× 130 0.9× 152 1.9× 12 0.3× 40 344
Eric Billaud France 12 185 0.9× 152 1.0× 115 0.8× 182 2.2× 69 1.8× 28 488
Catalina Robledano Spain 11 169 0.8× 114 0.7× 77 0.5× 147 1.8× 13 0.3× 15 321
M Mannazzu Italy 9 155 0.8× 197 1.2× 83 0.6× 97 1.2× 23 0.6× 14 385
Anna Danise Italy 13 382 1.9× 104 0.7× 289 2.0× 128 1.6× 19 0.5× 24 504
Jean‐Marc Mauboussin France 10 233 1.1× 187 1.2× 85 0.6× 196 2.4× 48 1.2× 11 545
María Jesús Vivancos Spain 12 166 0.8× 65 0.4× 87 0.6× 121 1.5× 23 0.6× 54 300
Roberta Gagliardini Italy 15 411 2.0× 120 0.8× 281 2.0× 129 1.6× 22 0.6× 65 544
Frederikke F. Rönsholt Denmark 10 156 0.8× 166 1.1× 123 0.9× 134 1.6× 37 0.9× 24 411
D. Rey France 14 212 1.0× 117 0.7× 141 1.0× 295 3.6× 15 0.4× 30 550

Countries citing papers authored by Monica Guffanti

Since Specialization
Citations

This map shows the geographic impact of Monica Guffanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Guffanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Guffanti more than expected).

Fields of papers citing papers by Monica Guffanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Guffanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Guffanti. The network helps show where Monica Guffanti may publish in the future.

Co-authorship network of co-authors of Monica Guffanti

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Guffanti. A scholar is included among the top collaborators of Monica Guffanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Guffanti. Monica Guffanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gona, Floriana, Chiara Tassan Din, Angelo Roberto Raccagni, et al.. (2024). Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report.. PubMed. 47(2). 190–193. 1 indexed citations
3.
Scarpellini, Paolo, et al.. (2024). Management of M. abscessus subsp. abscessus early-onset prosthetic joint infection: Case report and literature review. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 35. 100440–100440. 1 indexed citations
4.
Guffanti, Monica, et al.. (2024). Treatment of Candida glabrata native valve endocarditis with rezafungin: a case report. JAC-Antimicrobial Resistance. 6(2). dlae042–dlae042. 8 indexed citations
5.
Damanti, Sarah, Marta Cilla, Giordano Vitali, et al.. (2023). Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective. Nutrients. 15(22). 4727–4727. 2 indexed citations
6.
Muccini, Camilla, Laura Galli, Andrea Poli, et al.. (2018). Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological Suppression. JAIDS Journal of Acquired Immune Deficiency Syndromes. 79(5). 617–623. 7 indexed citations
7.
Spagnuolo, Vincenzo, Giovanna Travi, Laura Galli, et al.. (2013). Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer‐free, HIV‐1–infected patients. Cancer. 119(15). 2710–2719. 1 indexed citations
8.
Ferretti, Francesca, Simonetta Gerevini, B. Colombo, et al.. (2013). Susac’s syndrome as HIV-associated immune reconstitution inflammatory syndrome. AIDS Research and Therapy. 10(1). 22–22. 4 indexed citations
9.
Galli, Laura, Stefania Salpietro, G. Pellicciotta, et al.. (2012). Risk of type 2 diabetes among HIV-infected and healthy subjects in Italy. European Journal of Epidemiology. 27(8). 657–665. 69 indexed citations
10.
Spagnuolo, Vincenzo, Laura Galli, Stefania Salpietro, et al.. (2011). Ten‐year survival among HIV‐1‐infected subjects with AIDS or non‐AIDS‐defining malignancies. International Journal of Cancer. 130(12). 2990–2996. 21 indexed citations
11.
Guffanti, Monica, Andrea Caumo, Laura Galli, et al.. (2007). Switching to unboosted atazanavir improves glucose tolerance in highly pretreated HIV-1 infected subjects. European Journal of Endocrinology. 156(4). 503–509. 22 indexed citations
12.
Gianotti, Nicola, Monica Guffanti, Laura Galli, et al.. (2007). Electrocardiographic changes in HIV-infected, drug-experienced patients being treated with atazanavir. AIDS. 21(12). 1648–1651. 19 indexed citations
13.
Gianotti, Nicola, Laura Galli, Enzo Boeri, et al.. (2006). The 118I Reverse Transcriptase Mutation Is the Only Independent Genotypic Predictor of Virologic Failure to a Stavudine-Containing Salvage Therapy in HIV-1-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 41(4). 447–452. 7 indexed citations
14.
Seminari, Elena, Monica Guffanti, P. Villani, et al.. (2005). Steady-state pharmacokinetics of atazanavir given alone or in combination with saquinavir hard-gel capsules or amprenavir in HIV-1-infected patients. European Journal of Clinical Pharmacology. 61(7). 545–549. 12 indexed citations
15.
Seminari, Elena, Antonella Castagna, Armando Soldarini, et al.. (2005). Osteoprotegerin and bone turnover markers in heavily pretreated HIV‐infected patients. HIV Medicine. 6(3). 145–150. 44 indexed citations
16.
Codella, Roberto, Monica Guffanti, Antonella Castagna, Adriano Lazzarin, & Livio Luzi. (2005). Cross–sectional and retrospective questionnaire-trial to evaluate exercise habits in a sample of HIV–infected individuals with type 2 diabetes mellitus. Sport Sciences for Health. 1(2). 81–90. 1 indexed citations
17.
Guffanti, Monica, Elena Seminari, Nicola Gianotti, et al.. (2003). Pharmacokinetics of amprenavir given once or twice a day when combined with atazanavir in heavily pre-treated HIV-positive patients. AIDS. 17(18). 2669–2671. 11 indexed citations
18.
19.
Uberti‐Foppa, Caterina, Flavia Lillo, Maria Rosa Terreni, et al.. (1998). Cytomegalovirus Pneumonia in AIDS Patients. CHEST Journal. 113(4). 919–923. 29 indexed citations
20.
Finazzi, Renato, et al.. (1996). Unusual Presentation of Cryptococcosis in a Patient with AIDS. Clinical Infectious Diseases. 22(4). 709–709. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tanakorn Apornpong Breakdown of academic impact, for papers by Eric Billaud Breakdown of academic impact, for papers by Catalina Robledano Breakdown of academic impact, for papers by M Mannazzu Breakdown of academic impact, for papers by Anna Danise Breakdown of academic impact, for papers by Jean‐Marc Mauboussin Breakdown of academic impact, for papers by María Jesús Vivancos Breakdown of academic impact, for papers by Roberta Gagliardini Breakdown of academic impact, for papers by Frederikke F. Rönsholt Breakdown of academic impact, for papers by D. Rey
Rankless by CCL
2026